Please wait while the document is loaded.

A00116
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No.
112
Session of
2019
INTRODUCED BY YAW, SCAVELLO, LANGERHOLC, FOLMER, K. WARD,
STEFANO, BAKER, COSTA, KILLION, HAYWOOD, REGAN, YUDICHAK AND
BROWNE, JANUARY 23, 2019
REFERRED TO CONSUMER PROTECTION AND PROFESSIONAL LICENSURE,
JANUARY 23, 2019
AN ACT
Amending Title 35 (Health and Safety) of the Pennsylvania
Consolidated Statutes, in prescribing opioids to minors,
providing for prescribing opioids to individuals and further
providing for definitions, for prohibition and for procedure;
and making editorial changes.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. The heading of Chapter 52A of Title 35 of the
Pennsylvania Consolidated Statutes is amended to read:
CHAPTER 52A
PRESCRIBING OPIOIDS TO [MINORS] INDIVIDUALS
Section 2. The definitions of "medical emergency" and
"minor" in section 52A01 of Title 35 are amended and the section
is amended by adding a definition to read:
§ 52A01. Definitions.
The following words and phrases when used in this chapter
shall have the meanings given to them in this section unless the
context clearly indicates otherwise:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
* * *
" Health care facility. " The term shall have the same meaning
as provided in section 103 of the act of July 19, 1979 (P.L.130,
No.48), known as the Health Care Facilities Act.
* * *
"Medical emergency." A situation which, in a prescriber's
good faith professional judgment, creates an immediate threat of
serious risk to the life or physical health of [a minor] an
individual.
"Minor." An individual under 18 years of age. The term
excludes [an individual] a minor who is [emancipated by:
(1) marrying;
(2) entering the armed forces of the United States;
(3) being employed and self-sustaining; or
(4) otherwise being independent from the care and
control of the individual's parent, guardian or custodian.]:
(1) married or has been married;
(2) pregnant or has been pregnant;
(3) a member of the armed forces of the United States;
or
(4) legally emancipated.
* * *
Section 3. Section 52A03 of Title 35 is amended to read:
§ 52A03. Prohibition.
(a) Proscription.--A prescriber may not do any of the
following:
(1) Prescribe to [a minor] an individual a controlled
substance containing an opioid unless the prescriber complies
with section 52A04 (relating to procedure).
(2) Except as set forth in subsection (b) and subject to
A00116 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
section 52A04(c)(1), prescribe to [a minor] an individual
more than a seven-day supply of a controlled substance
containing an opioid.
(b) Exception.--Notwithstanding subsection (a)(1), a
prescriber may prescribe to [a minor] an individual more than a
seven-day supply of a controlled substance containing an opioid
if any of the following apply:
(1) In the professional medical judgment of the
prescriber, more than a seven-day supply of a controlled
substance containing an opioid is required to stabilize the
[minor's] individual's acute medical condition. In order for
this paragraph to apply, the prescriber must:
(i) document the acute medical condition in the
[minor's] individual's record with the prescriber; and
(ii) indicate the reason why a non-opioid
alternative is not appropriate to address the acute
medical condition.
(2) The prescription is for:
(i) management of pain associated with cancer;
(ii) use in palliative or hospice care; or
(iii) management of chronic pain not associated with
cancer.
Section 4. Section 52A04 of Title 35, amended October 24,
2018 (P.L.650, No.93), is amended to read:
§ 52A04. Procedure.
(a) Requirements.--Except as set forth in subsection (b),
before issuing [a minor] an individual the first prescription in
a single course of treatment for a controlled substance
containing an opioid, regardless of whether the dosage is
modified during that course of treatment, a prescriber shall do
A00116 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
all of the following:
(1) Assess whether the [minor] individual has taken or
is currently taking prescription drugs for treatment of a
substance use disorder.
(2) Discuss with the [minor and] individual or, if the
individual is a minor, with the minor and the minor's parent
or guardian or with an authorized adult, all of the
following:
(i) The risks of addiction and overdose associated
with the controlled substance containing an opioid.
(ii) The increased risk of addiction to controlled
substances to individuals suffering from mental or
substance use disorders.
(iii) The dangers of taking a controlled substance
containing an opioid with benzodiazepines, alcohol or
other central nervous system depressants.
(iv) Other information in the patient counseling
information section of the labeling for controlled
substances containing an opioid required under 21 C.F.R.
201.57(c)(18) (relating to specific requirements on
content and format of labeling for human prescription
drug and biological products described in § 201.56(b)(1))
deemed necessary by the prescriber.
(3) [Obtain] In the case of a minor, obtain written
consent for the prescription from the minor's parent or
guardian or from an authorized adult. The prescriber shall
record the consent on the form under section 52A02(b)(1)
(relating to administration). The following apply:
(i) The form must contain all of the following:
(A) The brand name or generic name and quantity
A00116 - 4 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
of the controlled substance containing an opioid
being prescribed and the amount of the initial dose.
(B) A statement indicating that a controlled
substance is a drug or other substance that the
United States Drug Enforcement Administration has
identified as having a potential for abuse.
(C) A statement certifying that the prescriber
engaged in the discussion under paragraph (2).
(D) The number of refills authorized by the
prescription under section 52A03(b) (relating to
prohibition).
(E) The signature of the minor's parent or
guardian or of an authorized adult and the date of
signing.
(ii) The form shall be maintained in the minor's
record with the prescriber.
(b) Exception.--Subsection (a) does not apply if the
[minor's] individual's treatment with a controlled substance
containing an opioid meets any of the following criteria:
(1) The treatment is associated with or incident to a
medical emergency as documented in the [minor's] individual's
medical record.
(2) In the prescriber's professional judgment, complying
with subsection (a) with respect to the [minor's]
individual's treatment would be detrimental to the [minor's]
individual's health or safety. The prescriber shall document
in the [minor's] individual's medical record the factor or
factors which the prescriber believed constituted cause for
not fulfilling the requirements of subsection (a).
(3) The medical treatment is rendered while the [minor]
A00116 - 5 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
individual remains admitted to a licensed health care
facility or remains in observation status in a licensed
health care facility.
(4) The prescriber is continuing a treatment initiated
by another member of the prescriber's practice, the
prescriber who initiated the treatment followed the
procedures outlined in subsection (a) and the prescriber who
is continuing the treatment is not changing the therapy in
any way other than dosage.
(c) Limited prescription.--If the individual who signs the
consent form under subsection (a)(3) is an authorized adult, the
prescriber:
(1) may prescribe not more than a single, 72-hour
supply; and
(2) shall indicate on the prescription the quantity that
is to be dispensed pursuant to the prescription.
Section 5. This act shall take effect in 180 days.
A00116 - 6 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17